Clarius AI vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Clarius Mobile Health
VS
by Pathway Labs

AI Verdict

Clarius AI and EchoNext are adjacent tools in cardiology, as both leverage AI for heart health but at different stages of diagnosis. Clarius AI enhances real-time ultrasound imaging and measurements for various specialties, including cardiology, providing immediate visual diagnostic support. EchoNext, on the other hand, analyzes standard ECGs to detect hidden structural heart disease, acting as a screening tool to identify patients who may need further cardiac ultrasound or other diagnostic follow-up.

Choose Clarius AI if…

Choose Clarius AI if you require real-time, portable ultrasound imaging with integrated AI guidance and automation for immediate diagnostic and procedural support. Its handheld scanners and AI features are ideal for clinicians across various specialties needing high-definition imaging, automated measurements, and anatomical overlays directly at the point of care.

View Clarius AI →

Choose EchoNext if…

Choose EchoNext if your primary need is to screen for hidden structural heart disease using standard ECGs in a non-invasive and cost-effective manner. This AI tool is best suited for broad deployment in settings ranging from major hospitals to community practices, providing valuable clinical decision support for early detection of conditions like heart failure, valve disease, and pulmonary hypertension.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Clarius AI EchoNext
Pricing Subscription-based with scanner purchase or one-time purchase with add-ons. Starts at $600/month
Deployment Cloud-based (Clarius Cloud) and mobile application (iOS/Android). Available through the OpenEvidence clinical decision support platform.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Yes AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Clarius AI

Clarius AI is integrated into handheld ultrasound scanners and an app, offering features like Auto Preset AI, real-time AI labeling (T-Modeu2122), and voice controls, which streamline workflows and assist both novice and experienced users. The app also includes in-app tutorials and allows for easy sharing and documentation. EchoNext, while integrated into the OpenEvidence platform, is primarily an ECG analysis tool, and its usability focuses on the interpretation of results rather than interactive real-time guidance during a procedure.

Clinical Value

EchoNext

EchoNext has demonstrated superior accuracy in detecting structural heart disease from ECGs compared to cardiologists, even those assisted by AI, in multiple validation studies. Clarius AI offers features that enhance image quality and automate measurements, which are valuable for improving efficiency and consistency in ultrasound examinations, but EchoNext's ability to identify hidden, high-risk conditions from a routine, inexpensive test presents a significant clinical breakthrough for early detection.

Pricing & Value

Clarius AI

Clarius AI offers a more transparent pricing model with a clear scanner purchase price and an optional annual membership that unlocks advanced features, cloud storage, and educational resources. EchoNext's tiered subscription model starts at $600/month, with additional costs for implementation, onboarding, and premium features, making its overall cost less immediately clear and potentially higher for many users. While both offer value, Clarius's upfront transparency and comprehensive membership for a broader set of features provide better perceived value.

Enterprise Readiness

Clarius AI

Clarius AI offers an Enterprise Software Solution designed to manage fleets of scanners for large healthcare institutions, along with HIPAA compliance, BAA, and DICOM/PACS integration, indicating strong enterprise readiness. EchoNext is deployed through the OpenEvidence clinical decision support platform, which is used by many physicians, suggesting good integration capabilities. However, Clarius's explicit enterprise-focused software and comprehensive ecosystem for managing multiple devices give it an edge in readiness for large-scale deployments.

Innovation

Clarius AI

Clarius AI demonstrates significant innovation through its real-time AI labeling (T-Modeu2122) for anatomical overlays, voice controls, and an open-source platform (Clarius Marketplace and SDK) that encourages third-party AI integrations. EchoNext's innovation lies in its FDA-cleared ability to detect hidden structural heart disease from standard ECGs, a novel application of AI. However, Clarius's broader range of interactive, real-time AI features directly integrated into a portable imaging device, coupled with its open platform for further development, suggests a more expansive and continuously evolving innovative ecosystem.

Support & Docs

Clarius AI

Clarius AI offers extensive support through its membership, which includes access to the Clarius Education Portal, interactive online training sessions, and a community of users. The in-app tutorials and real-time guidance features also serve as immediate support for users. While EchoNext is deployed via the OpenEvidence platform, details on specific support and documentation for EchoNext users are not as explicitly detailed as Clarius AI's comprehensive educational and support ecosystem.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Clarius AI EchoNext
Name Clarius AI EchoNext
Company Clarius Mobile Health Pathway Labs
Description Clarius AI is a suite of artificial intelligence features integrated into Clarius Mobile Health's handheld ultrasound scanners and app, designed to enhance image quality, automate measurements, and provide real-time guidance for clinicians across various specialties. EchoNext is an FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Key Features Auto Preset AI for automatic image optimization and anatomy detection, Real-time AI labeling and anatomical overlays (T-Modeu2122) for training and guidance, Semi-automatic measurements for various structures (e.g., tendons, prostate, fetal biometrics), Voice controls for hands-free operation during scans and procedures, Integrated patient reports and CPT medical codes for streamlined billing, Unlimited cloud storage and real-time telemedicine (with membership), High-definition imaging comparable to traditional cart-based ultrasound systems, Wireless and ultra-portable handheld ultrasound scanners AI-powered ECG analysis, Detection of hidden structural heart disease, Identifies heart failure risk, Screens for valve disease, Detects pulmonary hypertension indicators, Utilizes standard 12-lead ECGs, FDA-cleared technology, Non-invasive diagnostic support
Specialties Emergency Medicine, Obstetrics & Gynecology, Radiology Cardiology, Family Medicine, Hospital Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Clarius AI and EchoNext.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Clarius AI integrates into existing workflows by offering features like automated CPT code selection for billing and real-time telemedicine, with unlimited cloud storage for scans. EchoNext integrates through the OpenEvidence clinical decision support platform, which is used by a large number of U.S. physicians, allowing for AI-powered ECG analysis within a familiar environment.
Clarius AI enhances image quality and automates measurements for various structures, with AI labeling and anatomical overlays for guidance. EchoNext, trained on over 1 million heart rhythm and imaging records, demonstrated high diagnostic accuracy in detecting structural heart disease, outperforming cardiologists in a controlled evaluation with 77% accuracy compared to 64% for cardiologists.
Clarius AI is suitable for specialties like Emergency Medicine, OB/GYN, and Radiology, offering features like auto preset AI for image optimization, semi-automatic measurements, and real-time AI labeling for various applications including MSK, urology, and women's health. EchoNext is designed for Cardiology, Family Medicine, Hospital Medicine, and Internal Medicine, focusing on detecting hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, from standard ECGs.
Clarius AI aims to reduce the learning curve with features like T-Modeu2122, an AI-powered learning tool that provides real-time guidance with colored and textured anatomical overlays, available for various exams like rotator cuff, thyroid, and breast. EchoNext is integrated into the OpenEvidence platform, which may leverage existing familiarity with that system, and is designed to bridge the gap in detecting structural heart disease from routine ECGs.
While specific audit-trail features for Clarius AI are not detailed, the system offers integrated patient reports and CPT medical codes for streamlined billing, which can contribute to tracking usage. For EchoNext, the integration with a clinical decision support platform like OpenEvidence suggests that usage and recommendations would likely be logged within that system, though specific audit-trail features are not explicitly mentioned.
Clarius Mobile Health offers an Enterprise Software Solution specifically tailored for large healthcare institutions to manage multiple Clarius ultrasound scanners across different departments. EchoNext's availability through the OpenEvidence platform, which is used by a large number of U.S. physicians, suggests a scalable deployment model suitable for broad access across various practice sizes, from major hospitals to community practices.
AI Tool Finder
AI-powered search. Results may not be comprehensive.